Get the Stockscreener App
10.01
4.12%
-0.43
After Hours:
10.01
Ginkgo Bioworks Holdings Inc stock is traded at $10.01, with a volume of 1.46M.
It is down -4.12% in the last 24 hours and down -13.41% over the past month.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
See More
Previous Close:
$10.44
Open:
$10.5
24h Volume:
1.46M
Relative Volume:
0.89
Market Cap:
$471.37M
Revenue:
$217.11M
Net Income/Loss:
$-651.19M
P/E Ratio:
-0.7706
EPS:
-12.99
Net Cash Flow:
$-387.26M
1W Performance:
-10.22%
1M Performance:
-13.41%
6M Performance:
+50.53%
1Y Performance:
+59.65%
1-Day Range:
$9.95
$10.50
1-Week Range:
$9.95
$11.31
52-Week Range:
$5.00
$16.85
Ginkgo Bioworks Holdings Inc Stock (DNA) Company Profile
Name
Ginkgo Bioworks Holdings Inc
Sector
Industry
Phone
(877) 442-5362
Address
27 DRYDOCK AVENUE, BOSTON
Compare DNA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
DNA
Ginkgo Bioworks Holdings Inc
|
10.01 | 609.17M | 217.11M | -651.19M | -387.26M | -12.99 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Ginkgo Bioworks Holdings Inc Stock (DNA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-24 | Downgrade | BTIG Research | Neutral → Sell |
| May-10-24 | Downgrade | William Blair | Mkt Perform → Underperform |
| Nov-14-23 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Nov-09-23 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-02-23 | Downgrade | Goldman | Neutral → Sell |
| May-11-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Nov-29-22 | Initiated | Berenberg | Buy |
| Oct-04-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-18-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-02-22 | Resumed | Cowen | Outperform |
| Feb-23-22 | Initiated | Goldman | Neutral |
| Feb-01-22 | Initiated | BofA Securities | Neutral |
| Jan-28-22 | Initiated | BofA Securities | Buy |
| Jan-07-22 | Initiated | BTIG Research | Buy |
| Nov-29-21 | Initiated | Jefferies | Buy |
| Oct-13-21 | Initiated | Raymond James | Outperform |
| Oct-12-21 | Initiated | William Blair | Outperform |
| Sep-20-21 | Initiated | HSBC Securities | Buy |
View All
Ginkgo Bioworks Holdings Inc Stock (DNA) Latest News
American Century Companies Inc. Makes New Investment in Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Cubist Systematic Strategies LLC Buys 287,221 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Invesco Ltd. Grows Stock Position in Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Ginkgo Bioworks enters into $100M equity sales deal - MSN
EcoR1 Capital LLC Sells 281,016 Shares of Ginkgo Bioworks Holdings, Inc. $DNA - MarketBeat
Ginkgo Bioworks Holdings Inc. Chart Enters High Volatility ZoneTake Profit & High Yield Equity Trading Tips - classian.co.kr
Latham & Watkins Advises on Ginkgo Bioworks Holdings, Inc.’s US$100 Million At-the-Market Equity Offering Program - Latham & Watkins LLP
Published on: 2025-09-08 17:17:45 - beatles.ru
Ginkgo Bioworks Holdings, Inc. $DNA Stock Holdings Increased by PDT Partners LLC - MarketBeat
Institutional Investors in Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) See US$84m Decrease in Market Cap Last Week, Although Long-term Gains Have Benefitted Them. - 富途牛牛
Will breakout in Ginkgo Bioworks Holdings Inc. lead to full recoveryPortfolio Value Report & Risk Adjusted Swing Trade Ideas - Newser
Pattern recognition hints at Ginkgo Bioworks Holdings Inc. upsideTrade Volume Report & Community Consensus Stock Picks - Newser
Ginkgo Bioworks (NYSE:DNA) Stock Price Down 8.5%Should You Sell? - MarketBeat
How moving averages guide Ginkgo Bioworks Holdings Inc. tradingQuarterly Portfolio Report & Reliable Price Breakout Alerts - Newser
Should you avoid Ginkgo Bioworks Holdings Inc. stock right nowJuly 2025 Technicals & Community Verified Trade Signals - خودرو بانک
Will Ginkgo Bioworks Holdings Inc. stock go up soonJuly 2025 Summary & Trade Opportunity Analysis Reports - Newser
Developing predictive dashboards with Ginkgo Bioworks Holdings Inc. data2025 Retail Activity & Free Weekly Chart Analysis and Trade Guides - Newser
Will Ginkgo Bioworks Holdings Inc. stock recover after recent dropJuly 2025 Summary & Daily Stock Trend Reports - Newser
Detecting price anomalies in Ginkgo Bioworks Holdings Inc. with AIJuly 2025 Trends & Real-Time Market Sentiment Alerts - Newser
Ginkgo Bioworks Enters Sales Agreement for Stock Offering - MSN
Ginkgo Datapoints and Apheris Launch Antibody Developability Consortium - MarketScreener
DNAGinkgo Bioworks Holdings Inc Latest Stock News & Market Updates - Stock Titan
Is Ginkgo Bioworks Holdings Inc. stock reversal real or fake2025 Market Overview & Fast Moving Stock Trade Plans - Newser
Predicting Ginkgo Bioworks Holdings Inc. trend using moving averagesJuly 2025 Chart Watch & Reliable Momentum Entry Alerts - Newser
Combining price and volume data for Ginkgo Bioworks Holdings Inc.Market Risk Report & AI Powered Market Trend Analysis - Newser
Is Ginkgo Bioworks Holdings Inc. a candidate for recovery playTreasury Yields & AI Powered Trade Plan Recommendations - Newser
Visualizing Ginkgo Bioworks Holdings Inc. stock with heatmaps2025 Winners & Losers & Technical Entry and Exit Tips - Newser
Ginkgo Bioworks (NYSE:DNA) Rating Increased to Hold at Wall Street Zen - MarketBeat
Is a relief rally coming for Ginkgo Bioworks Holdings Inc. holdersWeekly Profit Report & Free Low Drawdown Momentum Trade Ideas - Newser
Is Ginkgo Bioworks Holdings Inc. stock ready for a breakoutProfit Target & Stepwise Entry/Exit Trade Alerts - Newser
Combining machine learning predictions for Ginkgo Bioworks Holdings Inc.2025 Market Overview & Long-Term Growth Portfolio Plans - Newser
Can Ginkgo Bioworks Holdings Inc. outperform under higher oil pricesJuly 2025 News Drivers & Technical Pattern Based Buy Signals - خودرو بانک
Volatility clustering patterns for Ginkgo Bioworks Holdings Inc.Treasury Yields & Daily Chart Pattern Signal Reports - Newser
What data driven models say about Ginkgo Bioworks Holdings Inc.’s futureEntry Point & Step-by-Step Swing Trade Plans - Newser
How to read the order book for Ginkgo Bioworks Holdings Inc.Quarterly Portfolio Summary & Growth Oriented Trading Recommendations - Newser
How Ginkgo Bioworks Holdings Inc. stock performs during market volatility2025 Key Highlights & Consistent Return Investment Signals - Newser
Is Ginkgo Bioworks Holdings Inc. stock a falling knife or bargain buyJuly 2025 Retail & Weekly Hot Stock Watchlists - خودرو بانک
Published on: 2025-09-02 22:33:59 - Newser
Will Ginkgo Bioworks Holdings Inc. outperform small cap indexesJuly 2025 Action & Reliable Entry Point Alerts - خودرو بانک
A | Is Ginkgo Bioworks Holdings, Inc. a strong candidate for buy and holdJuly 2025 Action & Reliable Entry Point Alerts - خودرو بانک
Using data models to predict Ginkgo Bioworks Holdings Inc. stock movementEarnings Growth Report & Technical Pattern Recognition Alerts - Newser
Ginkgo Bioworks: Structural Cost Issues Will Be Difficult To Resolve (DNA) - Seeking Alpha
What Fibonacci levels say about Ginkgo Bioworks Holdings Inc. reboundQuarterly Profit Report & Fast Entry and Exit Trade Plans - Newser
Ginkgo Bioworks Holdings Inc Stock (DNA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):